Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. Sanofi iAwards initiative is a multi-institutional partnership program designed to support collaborations with academic investigators to accelerate innovative early stage, disease-relevant research towards the clinic. With this program, Sanofi aims to fund cutting-edge translational research that can contribute to our early-stage pipeline and ultimately benefit patients.
An Exclusive Opportunity for Vanderbilt University and Vanderbilt University Medical School (VUMC) Innovators: Vanderbilt University-VUMC are among a select group of institutions globally invited to engage in this opportunity.
Program Highlights:
- Award winning proposals will receive $150,000 research funding including institutional direct and indirect costs for 12 months with up to 12 awards given in the 2023-2024 cycle
- Potential opportunity to convert iAwards projects to sponsored research programs
- Potential opportunity to subsequently create in-licensing and start-up opportunities within Sanofi’s early-stage portfolio
- Awardees will have access to Sanofi R&D expertise and guidance
For anyone interested in applying for Sanofi iAwards, please contact Swapneeta Date, Ph.D., Assistant Director of Life Sciences Collaborations. Submission deadline to CTTC: May 31st 2023.
